1. Home
  2. CSTL vs GHLD Comparison

CSTL vs GHLD Comparison

Compare CSTL & GHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • GHLD
  • Stock Information
  • Founded
  • CSTL 2007
  • GHLD 1960
  • Country
  • CSTL United States
  • GHLD United States
  • Employees
  • CSTL N/A
  • GHLD N/A
  • Industry
  • CSTL Medical Specialities
  • GHLD Finance: Consumer Services
  • Sector
  • CSTL Health Care
  • GHLD Finance
  • Exchange
  • CSTL Nasdaq
  • GHLD Nasdaq
  • Market Cap
  • CSTL 946.1M
  • GHLD 1.0B
  • IPO Year
  • CSTL 2019
  • GHLD 2020
  • Fundamental
  • Price
  • CSTL $29.81
  • GHLD $13.73
  • Analyst Decision
  • CSTL Strong Buy
  • GHLD Buy
  • Analyst Count
  • CSTL 7
  • GHLD 5
  • Target Price
  • CSTL $37.57
  • GHLD $16.60
  • AVG Volume (30 Days)
  • CSTL 457.0K
  • GHLD 14.4K
  • Earning Date
  • CSTL 11-04-2024
  • GHLD 11-06-2024
  • Dividend Yield
  • CSTL N/A
  • GHLD 3.65%
  • EPS Growth
  • CSTL N/A
  • GHLD N/A
  • EPS
  • CSTL 0.21
  • GHLD N/A
  • Revenue
  • CSTL $311,878,000.00
  • GHLD $829,864,000.00
  • Revenue This Year
  • CSTL $49.05
  • GHLD $50.09
  • Revenue Next Year
  • CSTL N/A
  • GHLD $25.76
  • P/E Ratio
  • CSTL $143.32
  • GHLD N/A
  • Revenue Growth
  • CSTL 62.43
  • GHLD 4.51
  • 52 Week Low
  • CSTL $16.97
  • GHLD $11.04
  • 52 Week High
  • CSTL $35.84
  • GHLD $18.26
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 45.16
  • GHLD 34.95
  • Support Level
  • CSTL $27.24
  • GHLD $13.97
  • Resistance Level
  • CSTL $29.02
  • GHLD $14.01
  • Average True Range (ATR)
  • CSTL 1.93
  • GHLD 0.33
  • MACD
  • CSTL -0.46
  • GHLD 0.01
  • Stochastic Oscillator
  • CSTL 29.88
  • GHLD 5.77

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

Share on Social Networks: